Braskem S.A. announced its fourth-quarter 2024 earnings, reporting recurrent cash generation of R$265 million for the period. The company also highlighted its full-year 2024 performance, achieving a recurring EBITDA of US$1.1 billion.
The full-year recurring EBITDA represents a significant 46% increase compared to 2023, demonstrating a strong recovery and improved operational efficiency. This growth was driven by higher international spreads and increased sales volumes across Brazil and Mexico.
Operating cash generation for the full year 2024 reached approximately R$4.1 billion, supported by the substantial increase in consolidated recurring EBITDA and a 31% reduction in operating CapEx. These results indicate a positive financial trajectory for Braskem.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.